Cargando…

Use of NQO1 status as a selective biomarker for oesophageal squamous cell carcinomas with greater sensitivity to 17-AAG

BACKGROUND: Oesophageal squamous cell carcinoma (OSCC) is a major health burden in Sub-Saharan Africa, and novel chemotherapies are urgently required to combat this disease. The heat shock protein 90 (HSP90) inhibitor 17-N-allylamino-17-demethoxygeldanamycin (17-AAG) has previously been proposed as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hadley, Katie E, Hendricks, Denver T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032580/ https://www.ncbi.nlm.nih.gov/pubmed/24886060 http://dx.doi.org/10.1186/1471-2407-14-334

Ejemplares similares

Topically applied Hsp90 inhibitor 17AAG inhibits ultraviolet radiation-induced cutaneous squamous cell carcinomas
por: Singh, Anupama, et al.
Publicado: (2014)

17AAG-induced internalisation of HER2-specific Affibody molecules
por: Göstring, Lovisa, et al.
Publicado: (2016)

Low intensity focused ultrasound (LOFU) modulates unfolded protein response and sensitizes prostate cancer to 17AAG
por: Saha, Subhrajit, et al.
Publicado: (2014)

Comparative Study of 17-AAG and NVP-AUY922 in Pancreatic and Colorectal Cancer Cells: Are There Common Determinants of Sensitivity?()
por: Mayor-López, Leticia, et al.
Publicado: (2014)

17-AAG Induces Cytoplasmic α-Synuclein Aggregate Clearance by Induction of Autophagy
por: Riedel, Michael, et al.
Publicado: (2010)

Effects of salinomycin and 17-AAG on proliferation of human gastric cancer cells in vitro
por: Zhang, Zuwen, et al.
Publicado: (2017)

17-AAG-Induced Activation of the Autophagic Pathway in Leishmania Is Associated with Parasite Death
por: Petersen, Antonio Luis de O. A., et al.
Publicado: (2021)

Effects of 17-allylamino-17-demethoxygeldanamycin (17-AAG) in transgenic mouse models of frontotemporal lobar degeneration and Alzheimer’s disease
por: Ho, Shuk Wai, et al.
Publicado: (2013)

Chemotherapeutic Potential of 17-AAG against Cutaneous Leishmaniasis Caused by Leishmania (Viannia) braziliensis
por: Santos, Diego M., et al.
Publicado: (2014)

Effects of 17-AAG on the cell cycle and apoptosis of H446 cells and the associated mechanisms
por: Zhao, Xuerong, et al.
Publicado: (2016)

NAD(P)H:Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG
por: Kasai, Shuya, et al.
Publicado: (2016)

Nobelprismodtager Aage Bohr er død
Publicado: (2009)

Nobelpristageren Aage Bohr er død
Publicado: (2009)

17-AAG Kills Intracellular Leishmania amazonensis while Reducing Inflammatory Responses in Infected Macrophages
por: Petersen, Antonio Luis de Oliveira Almeida, et al.
Publicado: (2012)

Combination effects of capecitabine, irinotecan and 17-AAG on colorectal cancer cell line (HT-29)
por: Zeynali-Moghaddam, Shima, et al.
Publicado: (2022)

Pauli letter collection: letter to Aage Bohr
por: Pauli, Wolfgang
Publicado: (2005)

Sublethal concentrations of 17-AAG suppress homologous recombination DNA repair and enhance sensitivity to carboplatin and olaparib in HR proficient ovarian cancer cells
por: Choi, Young Eun, et al.
Publicado: (2014)

Repercussion of Mitochondria Deformity Induced by Anti-Hsp90 Drug 17AAG in Human Tumor Cells
por: Vishal, Chaturvedi, et al.
Publicado: (2011)

Can RNAi-mediated hsp90α knockdown in combination with 17-AAG be a therapy for glioma?()
por: Mehta, Adi, et al.
Publicado: (2013)

The antitumor natural product tanshinone IIA inhibits protein kinase C and acts synergistically with 17-AAG
por: Lv, Chao, et al.
Publicado: (2018)

NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix
por: Ma, Yue, et al.
Publicado: (2014)

Tumor Suppressive Function of NQO1 in Cutaneous Squamous Cell Carcinoma (SCC) Cells
por: Zhang, Qing-Ling, et al.
Publicado: (2019)

Notch2 as a promising prognostic biomarker for oesophageal squamous cell carcinoma
por: Wang, Cong, et al.
Publicado: (2016)

Effect of mesoporous silica nanoparticles co-loading with 17-AAG and Torin2 on anaplastic thyroid carcinoma by targeting VEGFR2
por: Wang, Congcong, et al.
Publicado: (2020)

Molecular signature of response and potential pathways related to resistance to the HSP90 inhibitor, 17AAG, in breast cancer
por: Zajac, Magdalena, et al.
Publicado: (2010)

Schwann cell autophagy induced by SAHA, 17-AAG, or clonazepam can reduce bortezomib-induced peripheral neuropathy
por: Watanabe, T, et al.
Publicado: (2010)

Combination of Rapamycin, CI-1040, and 17-AAG Inhibits Metastatic Capacity of Prostate Cancer via Slug Inhibition
por: Ding, Guanxiong, et al.
Publicado: (2013)

17-AAG suppresses growth and invasion of lung adenocarcinoma cells via regulation of the LATS1/YAP pathway
por: Ye, Xiang-Yun, et al.
Publicado: (2015)

Regulation of Viral Replication, Apoptosis and Pro-Inflammatory Responses by 17-AAG during Chikungunya Virus Infection in Macrophages
por: Nayak, Tapas K., et al.
Publicado: (2017)

A Smart Hyperthermia Nanofiber-Platform-Enabled Sustained Release of Doxorubicin and 17AAG for Synergistic Cancer Therapy
por: Chen, Lili, et al.
Publicado: (2021)

A Novel Mechanism of 17-AAG Therapeutic Efficacy on HSP90 Inhibition in MYCN-Amplified Neuroblastoma Cells
por: Hanna, Reine, et al.
Publicado: (2021)

Association between alcohol consumption and oesophageal microbiota in oesophageal squamous cell carcinoma
por: Rao, Wenqing, et al.
Publicado: (2021)

Association of the GSTP1 and NQO1 Polymorphisms and Head and Neck Squamous Cell Carcinoma Risk
por: Cho, Chang Gun, et al.
Publicado: (2006)

Utilizing feline oral squamous cell carcinoma patients to develop NQO1-targeted therapy
por: Lundberg, Alycen P., et al.
Publicado: (2021)

17AAG Treatment Accelerates Doxorubicin Induced Cellular Senescence: Hsp90 Interferes with Enforced Senescence of Tumor Cells
por: Sarangi, Upasana, et al.
Publicado: (2012)

The Hsp90 inhibitor 17-AAG represses calcium-induced cytokeratin 1 and 10 expression in HaCaT keratinocytes
por: Miyoshi, Sadanori, et al.
Publicado: (2012)

Pertuzumab Increases 17-AAG-Induced Degradation of ErbB2, and This Effect Is Further Increased by Combining Pertuzumab with Trastuzumab
por: Hughes, Juliana Bentes, et al.
Publicado: (2012)

Mode of cell death induced by the HSP90 inhibitor 17-AAG (tanespimycin) is dependent on the expression of pro-apoptotic BAX
por: Powers, Marissa V, et al.
Publicado: (2013)

Cytotoxic effects of the newly-developed chemotherapeutic agents 17-AAG in combination with oxaliplatin and capecitabine in colorectal cancer cell lines
por: Mohammadian, Mahshid, et al.
Publicado: (2017)

17-AAG inhibits vemurafenib-associated MAP kinase activation and is synergistic with cellular immunotherapy in a murine melanoma model
por: Joshi, Sandeep S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_97956u906fvqclad658ti6hc2i